Email this article 
Hide
Show all
Original Research
The cost-effectiveness of managed care regarding chronic medicine prescriptions in a selected medical scheme
Curationis | Vol 21, No 4 | a684 |
DOI: https://doi.org/10.4102/curationis.v21i4.684
| © 1998 K. Day, S. Booyens
| This work is licensed under CC Attribution 4.0
Submitted: 27 September 1998 | Published: 27 September 1998
Submitted: 27 September 1998 | Published: 27 September 1998
About the author(s)
K. Day, UNISA, South AfricaS. Booyens, UNISA, South Africa
Full Text:
PDF (227KB)Abstract
The purpose of the study was to examine the cost-effectiveness of managed care interventions with respect to prescriptions for chronic illness sufferers enrolled with a specific medical scheme. The illnesses included, were epilepsy, hypertension, diabetes and asthma. The managed care interventions applied were a primary discount; the use of preferred provider pharmacies, and drug utilization review. It was concluded that the managed care interventions resulted in some real cost savings.
Keywords
No related keywords in the metadata.
Metrics
Total abstract views: 3946Total article views: 2598
Crossref Citations
1. Examining potential health gains arising from reduced risk consumption in South Africa via the PRIME model
Steven F. Koch
Discover Social Science and Health vol: 4 issue: 1 year: 2024
doi: 10.1007/s44155-024-00093-1
2. The costs of interventions for type 2 diabetes mellitus, hypertension and cardiovascular disease in South Africa – a systematic literature review
Sithabiso D. Masuku, Nkgomeleng Lekodeba, Gesine Meyer-Rath
BMC Public Health vol: 22 issue: 1 year: 2022
doi: 10.1186/s12889-022-14730-4
3. The State of Health Economic Research in South Africa
Paul Gavaza, Karen L. Rascati, Abiola O. Oladapo, Star Khoza
PharmacoEconomics vol: 30 issue: 10 first page: 925 year: 2012
doi: 10.2165/11589450-000000000-00000